These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15301287)

  • 1. Amnioreduction.
    Coviello D; Bonati F; Montefusco SM; Mastromatteo C; Fabietti I; Rustico M
    Acta Biomed; 2004; 75 Suppl 1():31-3. PubMed ID: 15301287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes in severe polyhydramnios: no increase in risk in patients needing amnioreduction for maternal pain or respiratory distress.
    Kleine RT; Bernardes LS; Carvalho MA; de Carvalho MH; Krebs VL; Francisco RP
    J Matern Fetal Neonatal Med; 2016 Dec; 29(24):4031-4. PubMed ID: 26948899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedure-related complications of rapid amniodrainage in the treatment of polyhydramnios.
    Leung WC; Jouannic JM; Hyett J; Rodeck C; Jauniaux E
    Ultrasound Obstet Gynecol; 2004 Feb; 23(2):154-8. PubMed ID: 14770396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amnioreduction for treatment of severe polyhydramnios.
    Piantelli G; Bedocchi L; Cavicchioni O; Verrotti C; Cavallotti D; Fieni S; Gramellini D
    Acta Biomed; 2004; 75 Suppl 1():56-8. PubMed ID: 15301292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-volume therapeutic amniocentesis in the treatment of hydramnios.
    Elliott JP; Sawyer AT; Radin TG; Strong RE
    Obstet Gynecol; 1994 Dec; 84(6):1025-7. PubMed ID: 7970458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amnioreduction in cases of polyhydramnios: Indications and outcomes in singleton pregnancies without fetal interventions.
    Erfani H; Diaz-Rodriguez GE; Aalipour S; Nassr A; Rezaei A; Gandhi M; Mendez-Figueroa H; Aagaard KM; Shamshirsaz AA
    Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():126-128. PubMed ID: 31160132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amnioreduction vs expectant management in pregnancies with moderate to severe polyhydramnios.
    Soni S; Paidas Teefey C; Gebb JS; Khalek N; Neary K; Miller K; Moldenhauer JS
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101192. PubMed ID: 37858792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amnioreduction in treatment of increased amniotic fluid volume].
    Stojić S; Novakov-Mikić A; Bogavac M; Mandić A
    Med Pregl; 2004; 57(11-12):579-83. PubMed ID: 16107006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the amniotic fluid and neonatal outcome.
    Volante E; Gramellini D; Moretti S; Kaihura C; Bevilacqua G
    Acta Biomed; 2004; 75 Suppl 1():71-5. PubMed ID: 15301296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between higher intra-amniotic pressures in polyhydramnios and maternal symptoms.
    Katsura D; Takahashi Y; Iwagaki S; Chiaki R; Asai K; Koike M; Yasumi S; Furuhashi M; Murakami T
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():62-65. PubMed ID: 30797177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes].
    Lu D; Wang ZX; Wang XL; Gu XW; Wang YX; Fu D
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):20-4. PubMed ID: 16635322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes.
    Shim SS; Romero R; Hong JS; Park CW; Jun JK; Kim BI; Yoon BH
    Am J Obstet Gynecol; 2004 Oct; 191(4):1339-45. PubMed ID: 15507963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess of amniotic fluid: pathophysiology, correlated diseases and clinical management.
    Nobile de Santis MS; Radaelli T; Taricco E; Bertini S; Cetin I
    Acta Biomed; 2004; 75 Suppl 1():53-5. PubMed ID: 15301291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes.
    Ramsey PS; Lieman JM; Brumfield CG; Carlo W
    Am J Obstet Gynecol; 2005 Apr; 192(4):1162-6. PubMed ID: 15846196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between change in amniotic fluid index and volume of fluid removed at amnioreduction.
    Denbow ML; Sepulveda W; Ridout D; Fisk NM
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):529-32. PubMed ID: 9380310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amnioreduction in the management of polyhydramnios complicating singleton pregnancies.
    Dickinson JE; Tjioe YY; Jude E; Kirk D; Franke M; Nathan E
    Am J Obstet Gynecol; 2014 Oct; 211(4):434.e1-7. PubMed ID: 24881825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery?
    Tarim E; Bağiş T; Kiliçdağ EB; Sezgin N; Yanik F
    J Perinat Med; 2005; 33(6):524-9. PubMed ID: 16318616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of pregnancies with preterm premature rupture of membranes.
    Khashoggi TY
    Saudi Med J; 2004 Dec; 25(12):1957-61. PubMed ID: 15711675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chorioamnionitis risk and neonatal outcome in preterm premature rupture of membranes.
    Osmanağaoğlu MA; Unal S; Bozkaya H
    Arch Gynecol Obstet; 2005 Jan; 271(1):33-9. PubMed ID: 15655697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death (apoptosis) in placentas from normal pregnancy and pregnancy complicated by term (t) and preterm (p) premature rupture of membranes (PROM).
    Tanir HM; Sener T; Artan S; Kaytaz B; Sahin-Mutlu F; Ozen ME
    Arch Gynecol Obstet; 2005 Dec; 273(2):98-103. PubMed ID: 16001193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.